SEC Tracker
Get the app

Quanome Technologies

QNME

Listing: 2 notices since Jan 2026, 1 open (newest Jul 10)

Dilution Known so far: no new shares beyond today's 34.4M · shelf room about $459K · not yet read: warrants, converts, options, ATM; 8.0M registered for resale, likely already outstanding, not counted. Every source

Revenue $5.9M (+112%), diluted EPS −$0.36 in the year ended Jun 30, 2026, from a 10-K filed .

Insiders No Form 3, 4 or 5 filings at Quanome Technologies in the last 90 days. Every trade

Next: earnings expected ~Nov 16; 10-Q due by Nov 16

Get email alertsGet the app
Legal name
Quanome Technologies, Inc.
CIK
1996192
Sector
Transportation and logistics
  • Cash$670KCash down $4.1M vs the Jun 2025 quarter
  • Cash from operations, last quarter−$143KCash from operations down $344K vs the Jun 2025 quarter
  • Shares outstanding34.4M+98% from 17.4M on Oct 10, 2025

From the 10-K 0001213900-26-103571 on EDGAR

8-K filed

Quanome Receives $13.5M Prepayment for AI Services

  • $13.5 million prepayment for AI inference services
  • First major financial milestone under new AI business

Read the 8-K on EDGARTables over time

Cash runway and key numbers

Not burning cash: operating cash flow over the latest reported quarters was zero or positive.

From the 10-K 0001213900-26-103571 for the period ended Jun 30, 2026, as tagged in its XBRL. An estimate from reported figures, not a forecast or advice.

Every quarter as a table
Key numbers, last 8 quarters (— means no figure was tagged for that quarter; each share count is the one on the report's cover, with the cover date under it)
Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Cash$2.7M$1.1M$1.5M$4.8M$4.5M$1.6M$1.3M$670K
Quarterly burn$1.4M$530Knonenone$4.0M$453Knone$143K
Shares outstanding7.5Mas of Nov 147.5Mas of Feb 147.5M17.4Mas of Oct 1017.4Mas of Nov 1934.4M34.4M34.4Mas of Sep 22

Every line item over time, with Excel and CSV export

Get an email when Quanome Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What Quanome Technologies does

Quanome Technologies, Inc. operates through its subsidiary Hupan Pharmaceutical, distributing pharmaceutical products in China. It also explores quantum-related technologies and AI compute capacity, which are in early development stages. Source

Products

  • Infusion products Product

    Infusion products are distributed to hospitals, pharmaceutical distributors and other healthcare providers. Source

  • Foods for special medical purposes Product

    Foods for special medical purposes are distributed to hospitals, pharmaceutical distributors and other healthcare providers. Source

  • Specialty pharmaceuticals Product

    Specialty pharmaceuticals are distributed to hospitals, pharmaceutical distributors and other healthcare providers. Source

  • AI compute capacity and managed inference services Service

    AI compute capacity and managed inference services are provided through the subsidiary XDT Infrastructure I, LLC. Source

  • Quantum-related and certain other advanced technology activities In development

    Quantum-related and certain other advanced technology activities are being evaluated and developed through the subsidiary Quantum Nexus. Source

Headquarters
Quanome Technologies, Inc. is headquartered in New York, NY. Source
Employees
As of June 30, 2026, the company had 27 full-time employees. Source
Customers
Hospitals, pharmaceutical distributors and other healthcare providers purchase the company's products. Source

From the 10-K filed Sep 25, 2026, Item 1, Business. Open the filing. Each line links to the passage it restates. The company's own description, summarized; not investment advice.

All filings

Results, 8-Ks and Major or Notable filings come first, then registrations and share actions, then everything else, newest first. Routine filings are kept here unmarked; insider filings are summed up in one line.

Results, 8-Ks and key filings

  2. Financing: agreement (8-K) with a 424B5 prospectus filed the same day. 424B5 on EDGAR

  9. 8 more 8-K filings, Sep 21 to Jun 5
  10. 14 older filings, May 19 to Aug 21, 2025

No Form 3, 4 or 5 filings at Quanome Technologies in the last 90 days. Every QNME insider trade

Financing and share filings

  3. 2 more S-3/A filings, Sep 2 to Aug 5

Other filings

Older filings on EDGAR

Shares registered for resale

Known so far: no new shares beyond today's 34.4M · shelf room about $459K · not yet read: warrants, converts, options, ATM.

8.0M registered for resale, already counted in today's shares where issued; all likely already outstanding.

Not read yet: warrants, convertible notes, options and RSUs and an ATM program.

What could become new QNME shares

Listing compliance

1 open of 2 listing notices from 8-K item 3.01.

  • Jul 10, 2026 Bid price under $1 (Nasdaq 5550(a)(2)), cure by Jan 4, 2027
  • Jan 9, 2026 8-K item 3.01 notice; rule and cure date not stated, see the filing

Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. All open notices

Trading halts

No trading halts for QNME since Feb 22, 2019, when SEC Tracker began reading the Nasdaq Trader feed.

Halt times and codes from the Nasdaq Trader trade halts feed, which lists Nasdaq and other exchange halts. Filings matched by SEC Tracker from EDGAR by company and time. Not investment advice. All recent halts

Fails-to-deliver: 25,143 shares on Aug 31, 2026, per SEC data

Coming up

  1. Earnings, expected
  2. 10-Q, expected (deadline Nov 16)

Stated dates are as each filing on EDGAR gives them; an expected date is estimated from the company's past filing dates, the same estimate as the top of the page. Not investment advice.

Quanome Technologies shares and listing

From the company's own filings; each row names its source. Not investment advice.

  • Shares outstandingas of Sep 22, 2026 (10-K filed Sep 25)34.4Mwarrants, notes and options not read yet, so fully diluted is not known
  • Listing compliance8-K item 3.012 notices since Jan 2026, 1 opencure by Jan 4, 2027

Insider activity

No Form 3, 4 or 5 filings at Quanome Technologies in the last 90 days.

All QNME insider trades